Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
Don’t Wait to Escalate—Getting Aggressive in PH Management
Don’t Wait to Escalate—Getting Aggressive in PH Management
Practical Implications of New Treatments in Clinical Practice
Practical Implications of New Treatments in Clinical Practice
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
Myosin inhibitors: recent clinical data and applications in HCM and HF
Myosin inhibitors: recent clinical data and applications in HCM and HF
Evaluation of the complex cardiac pathophysiology in HCM
Evaluation of the complex cardiac pathophysiology in HCM
Recommendations on the management of HCM in guidelines: European vs. American views
Recommendations on the management of HCM in guidelines: European vs. American views
Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals
Optimizing clinical care in patients with cardiorenal disease for achieving long-term goals
Implementing the latest evidence on novel potassium binders for achieving long-term goals
Implementing the latest evidence on novel potassium binders for achieving long-term goals
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
